News
on
|
News Release
NIH-funded study finds higher dose is not more effective at reducing serious flu complications in this high-risk group High-dose influenza (commonly known as flu) vaccines are no better than regular-dose influenza vaccines in reducing deaths and hospitalizations among patients with underlying heart disease, according to a large study publishing in...
|
News Release
Using a life support machine to replicate the functions of the heart and lungs significantly improved the survival of people who suffered from out-of-hospital cardiac arrest, according to a new study published today in The Lancet . The treatment program involving the life support machine called extracorporeal membrane oxygenation (ECMO) proved so...
|
Research Feature
Not so long ago, when doctors saw a patient with the inflammatory skin condition psoriasis, their first line of attack was to address the signs they could see—red, itchy, scaly patches, mostly on the knees, elbows, trunk and scalp. But research over the last several years is forcing a rethinking of the very nature of this common disease. Rather...
|
News Release
The National Institutes of Health has launched two of three adaptive Phase 3 clinical trials evaluating the safety and effectiveness of varying types of blood thinners to treat adults diagnosed with COVID-19. Part of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative, these trials will be conducted at more than 100...
|
News Release
NIH-funded studies find stents, surgery provide higher quality of life for those with chest pain Invasive procedures such as bypass surgery and stenting—commonly used to treat blocked arteries—are no better at reducing the risk for heart attack and death in patients with stable ischemic heart disease than medication and lifestyle changes alone...
|
Research Features
Chris Camp recalls the early days of the HIV/AIDS epidemic, when being diagnosed as HIV positive was considered a virtual death sentence. Doctors had no medications that could really help. People with the disease often did not survive more than a year or two. Camp, now 63, says he personally lost more than 500 friends. Among them: his first husband...
|
Media Availability
WHAT: June 12-18 is National Men’s Health Week and experts from the National Heart, Lung, and Blood Institute (NHLBI) are available to discuss research findings related to some of the more serious medical challenges that disproportionately affect men—sleep apnea, excess belly fat, and high blood pressure. All are linked to an increased risk for...
|
News Release
In a study published online today in the New England Journal of Medicine , researchers found that cardiopulmonary resuscitation (CPR) administered by emergency medical services (EMS) providers following sudden cardiac arrest that combines chest compressions with interruptions for ventilation resulted in longer survival times and shorter hospital...
|
News Release
WHAT: Scientists now report a new way to assess cholesterol that shows promise for evaluating the increased heart attack risk observed in patients with psoriasis, a common inflammatory skin disease. The new technique measures the function of high-density lipoprotein (HDL), known as “good” cholesterol, rather than HDL cholesterol concentration. The...
|
News Release
|
News Release
Administering to patients stem cells derived from their own bone marrow either three or seven days after a heart attack is safe but does not improve heart function six months later, according to a clinical trial supported by the National Institutes of Health. The results of the trial, called Transplantation In Myocardial Infarction Evaluation (TIME...
|
News Release
An international multi-site trial has launched to determine whether a common anti-inflammatory drug can reduce heart attacks, strokes, and deaths due to cardiovascular disease in people at high risk for them. This study is being supported by the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health...
|
Research Feature
Nine studies focus on heart, lung, and blood diseases The National Institutes of Health has funded nine new studies that will develop induced pluripotent stem cells , or iPS cells, from patients with genetic variations that have been associated with coronary artery disease, pulmonary hypertension, clotting disorders, diabetes, and other conditions...